Discover J&J
Medicines & therapies
Medical devices & technology
Discover J&J
Medicines & therapies
Medical devices & technology
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Issue Briefs
Perspectives
& insights
About us
Menu
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Issue Briefs
Perspectives
& insights
About us
Show Search
Search Query
Clear
Submit Search
Dictate search request
Listening...
Search Results
No Results
See all results
Sorry, I don't understand. Please try again
Search results
Search Query
Submit Search
Listening...
There are 97 results that match your search.
Access
August 7, 2023
Assessment of racial & ethnic inequities in copay card utilization & enrollment in copay adjustment programs
Read more
Value
October 27, 2025
Are cost-effectiveness analysis thresholds fit for purpose for U.S. decision-making?
Read more
Access
October 9, 2025
Does the 340B Program unintentionally reinforce patterns of hospital consolidation in the United States?
Research presented at the 2025 ISPOR Conference offers a new perspective on this issue.
Read more
Access
July 18, 2025
Are 340B hospital child sites reaching underserved communities, or are they drifting away from the Program’s original intent?
Read more
Transparency Report & Issue Briefs
November 1, 2022
How insurers divert copay support meant for patients
Janssen health equity Policy Brief
Read more
Research
Read more
Perspectives & insights
October 2, 2025
Expert Insights: What do we know about the 340B Program? A conversation with Professor Neal Masia
Read more
Perspectives & insights
September 10, 2025
CBO report confirms analyses that Americans pay a steep price for runaway 340B costs
Read more
Perspectives & insights
October 3, 2025
Follow-on innovation: Anything but trivial
Read more
Perspectives & insights
October 27, 2025
Research highlights the arbitrary nature of thresholds in cost-effectiveness analysis
Read more
7 of 10
